<SEC-DOCUMENT>0001193125-24-161589.txt : 20240614
<SEC-HEADER>0001193125-24-161589.hdr.sgml : 20240614
<ACCEPTANCE-DATETIME>20240614160534
ACCESSION NUMBER:		0001193125-24-161589
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20240614
DATE AS OF CHANGE:		20240614
EFFECTIVENESS DATE:		20240614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TScan Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001783328
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				825282075
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280212
		FILM NUMBER:		241044709

	BUSINESS ADDRESS:	
		STREET 1:		880 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		857-399-9500

	MAIL ADDRESS:	
		STREET 1:		880 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d820577ds8.htm
<DESCRIPTION>FORM S-8
<TEXT>
<HTML><HEAD>
<TITLE>FORM S-8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on June&nbsp;14, 2024 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-&#8195;&#8195;&#8195;</FONT> </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">S-8</FONT></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>TSCAN THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">82-5282075</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(State or other jurisdiction of<BR>incorporation or organization)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(I.R.S. Employer<BR>Identification No.)</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>830 Winter Street</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Waltham, Massachusetts</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>02451</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of Principal Executive Offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TSCAN THERAPEUTICS, INC. AMENDED AND RESTATED 2021 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Full title of the plan) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Gavin
MacBeath </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TScan Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>830 Winter Street </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Waltham, Massachusetts 02451 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name and address of agent for service) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(857) <FONT
STYLE="white-space:nowrap">399-9500</FONT></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Telephone number, including area code, of agent for service) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to: </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Mitchell S. Bloom, Esq. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>William D. Collins, Esq. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Finnbarr Murphy, Esq. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Goodwin Procter LLP </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>100
Northern Avenue </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Boston, Massachusetts 02210 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(617) <FONT STYLE="white-space:nowrap">570-1000</FONT></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated
filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company,&#148; and &#147;emerging growth company&#148; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated&nbsp;filer</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&#8194;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> registers 2,000,000 additional shares of the Registrant&#146;s common stock,
$0.0001 par value per share (&#147;Common Stock&#148;), under the TScan Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan (the &#147;2021 Plan&#148;). The additional shares are of the same class as other securities relating to the
2021 Plan for which the Registrant&#146;s registration statements filed on Form <FONT STYLE="white-space:nowrap">S-8</FONT> with the Securities and Exchange Commission on <A HREF="http://www.sec.gov/Archives/edgar/data/1783328/000119312521216925/d178021ds8.htm">July&nbsp;16,
 2021</A> (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-257941),</FONT> <A HREF="http://www.sec.gov/Archives/edgar/data/1783328/000119312522069921/d314740ds8.htm">March&nbsp;9, 2022</A> (Registration
<FONT STYLE="white-space:nowrap">No.&nbsp;333-263380),</FONT> <A HREF="http://www.sec.gov/Archives/edgar/data/1783328/000119312523063834/d312398ds8.htm">March&nbsp;8, 2023</A> (Registration
<FONT STYLE="white-space:nowrap">No.&nbsp;333-270343),</FONT> <A HREF="http://www.sec.gov/Archives/edgar/data/1783328/000119312523169052/d516923ds8.htm">June&nbsp;16, 2023</A> (Registration
<FONT STYLE="white-space:nowrap">No.&nbsp;333-272733)</FONT> and <A HREF="http://www.sec.gov/Archives/edgar/data/1783328/000119312524060705/d781311ds8.htm">March&nbsp;6, 2024</A> (Registration
<FONT STYLE="white-space:nowrap">No.&nbsp;333-277695)</FONT> are effective. The information contained in the Registrant&#146;s registration statements on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (Registration
<FONT STYLE="white-space:nowrap">No.&nbsp;333-257941,</FONT> <FONT STYLE="white-space:nowrap">No.&nbsp;333-263380,</FONT> <FONT STYLE="white-space:nowrap">No.&nbsp;333-270343,</FONT> <FONT STYLE="white-space:nowrap">No.&nbsp;333-272733</FONT> <FONT
STYLE="white-space:nowrap">and&nbsp;No.&nbsp;333-277695)</FONT> is hereby incorporated by reference pursuant to General Instruction E, except with respect to Item 8. Exhibits thereof. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Part II </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;8. Exhibits. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP><B>Exhibit<BR>No.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1783328/000119312521219696/d172723dex31.htm">Amended and Restated Certificate of Incorporation of the Registrant (Incorporated by reference to Exhibit 3.1 to the Registrant&#146;s Current
 Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-40603)</FONT> filed with the Securities and Exchange Commission on July&nbsp;20, 2021). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1783328/000119312521219696/d172723dex32.htm">Amended and Restated <FONT STYLE="white-space:nowrap">By-laws</FONT> of the Registrant (Incorporated by reference to Exhibit 3.2 to the Registrant&#146;s
 Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-40603)</FONT> filed with the Securities and Exchange Commission on July&nbsp;20, 2021). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1783328/000119312521129264/d107876dex42.htm">Fourth Amended and Restated Investors&#146; Rights Agreement by and among the Registrant and the other parties thereto, dated January&nbsp;
15, 2021(Incorporated by reference to Exhibit 4.2 to the Registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;
333-</FONT> 255491) filed with the Securities and Exchange Commission on April&nbsp;23, 2021). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>5.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d820577dex51.htm">Opinion of Goodwin Procter LLP. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d820577dex231.htm">Consent of Deloitte&nbsp;&amp; Touche LLP, independent registered public accounting firm. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d820577dex51.htm">Consent of Goodwin Procter LLP (included in Exhibit 5.1). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Power of Attorney (included on signature page). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1783328/000119312524161151/d785285dex101.htm">TScan Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan (Incorporated by reference to Exhibit 10.1 to the Registrant&#146;s
 Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (File No.&nbsp;001-40603) filed with the Securities and Exchange Commission on June&nbsp;14, 2024.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>107.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d820577dexfilingfees.htm">Filing Fee Table. </A></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Filed herewith. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on Form <FONT STYLE="white-space:nowrap">S-8</FONT> and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Waltham,
Commonwealth of Massachusetts, on June&nbsp;14, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>TScan Therapeutics, Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gavin MacBeath</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Gavin MacBeath, Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal Executive
Officer)</P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>POWER OF ATTORNEY AND SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Gavin MacBeath and Jason A.
Amello, and each of them, as such person&#146;s true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, with full power of substitution and resubstitution in each of them, for
such person in such person&#146;s, place and stead, in any and all capacities, to sign for us and in our names in the capacities indicated below the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> of TScan Therapeutics,
Inc., and any or all amendments (including post-effective amendments), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in connection
therewith and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT>
and agents or any of them, or substitutes of any of them, may lawfully do or cause to be done by virtue hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the
requirements of the Securities Act of 1933, as amended, this Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> has been signed by the following persons in the capacities and on the dates indicated. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Gavin MacBeath</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Gavin MacBeath</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Chief Executive Officer and Director (Principal Executive Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;14, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Jason A. Amello</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Jason A. Amello</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Chief Financial Officer (Principal Accounting Officer and Principal Financial Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;14, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Stephen Biggar</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Stephen Biggar, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;14, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/Barbara Klencke, M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Barbara Klencke, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;14, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Garry Nicholson</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Garry Nicholson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;14, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Gabriela Gruia</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;14, 2024</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Gabriela Gruia, M.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Katina Dorton</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Katina Dorton, J.D., M.B.A.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;14, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ R. Keith Woods</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;14, 2024</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">R. Keith Woods</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d820577dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g820577dsp001.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goodwin Procter LLP</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 Northern Avenue</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston, MA 02210</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">goodwinlaw.com</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">+1 617 570 1000</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">June&nbsp;14, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TScan Therapeutics, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">830 Winter Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Waltham, Massachusetts 02451 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Securities Being Registered under Registration Statement on Form
<FONT STYLE="white-space:nowrap">S-8</FONT></U> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as counsel to you in connection with your filing of a Registration
Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> (the &#147;Registration Statement&#148;) pursuant to the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), on or about the date hereof relating to an aggregate of
2,000,000 additional shares (the &#147;Shares&#148;) of Common Stock, $0.0001 par value per share (&#147;Common Stock&#148;), of TScan Therapeutics, Inc., a Delaware corporation (the &#147;Company&#148;), that may be issued pursuant to the TScan
Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan (the &#147;2021 Plan&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have reviewed such documents and made such examination
of law as we have deemed appropriate to give the opinion set forth below. We have relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinion set forth below, on certificates of
officers of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of the opinion set forth below, we have assumed that, at the time Shares are issued, the total number of then
unissued Shares, when added to the number of shares of Common Stock issued, subscribed for, or otherwise committed to be issued, does not exceed the number of shares of Common Stock authorized by the Company&#146;s certificate of incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The opinion set forth below is limited to the Delaware General Corporation Law. Based on the foregoing, we are of the opinion that the Shares have been duly
authorized and, when delivered against payment therefor in accordance with the terms of the Plans, will be validly issued, fully paid and nonassessable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion letter and the opinion it contains shall be interpreted in accordance with the Core Opinion Principles as published in 74 <I>Business Lawyer</I>
815 (Summer 2019). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the inclusion of this opinion as Exhibit&nbsp;5.1 to the Registration Statement. In giving our consent, we do not
admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations thereunder. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TScan Therapeutics, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 14, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours,</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/<SMALL>S</SMALL>/GOODWIN PROCTER LLP</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">GOODWIN PROCTER LLP</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d820577dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the incorporation by reference in this Registration <FONT STYLE="white-space:nowrap">Statement&nbsp;on&nbsp;Form&nbsp;S-8</FONT> of&nbsp;our
report dated March&nbsp;6, 2024 relating to the financial statements of TScan Therapeutics, Inc., appearing in the Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K&nbsp;of</FONT> TScan Therapeutics, Inc. for the year ended
December&nbsp;31, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Deloitte&nbsp;&amp; Touche LLP </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston, Massachusetts </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;14, 2024 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>d820577dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML><HEAD>
<TITLE>EX-FILING FEES</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 107.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Calculation of Filing Fee Tables </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">S-8</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Form Type) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TScan
Therapeutics, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Exact Name of Registrant as Specified in its Charter) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Table 1: Newly Registered Securities </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; padding-left:8pt">Security Type</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Security</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Class</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Title</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Fee<BR>Calculation<BR>Rule</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Registered(1)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Proposed</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Maximum</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Offering<BR>Price</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">per Share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Maximum</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Aggregate</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Offering Price</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Fee Rate</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Amount of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Registration<BR>Fee</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; padding-left:8pt">Equity</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">Common&nbsp;Stock,<BR>$0.0001&nbsp;par&nbsp;value<BR>per share</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">457(h)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">2,000,000<BR>shares(2)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">$8.42(3)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">$16,840,000</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">$0.0001476</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">$2,485.59</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" COLSPAN="7" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="7" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; padding-left:8pt">Total Offering Amounts</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">$16,840,000</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">$2,485.59</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" COLSPAN="7" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="7" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; padding-left:8pt">Total Fee Offsets</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">$0</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" COLSPAN="7" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="7" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">Net Fee Due</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">$2,485.59</TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), this
registration statement shall also cover any additional shares of common stock, $0.0001 par value per share (the &#147;Common Stock&#148;), which become issuable under the TScan Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan (the
&#147;2021 Plan&#148;) by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrant&#146;s outstanding
shares of Common Stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents an increase of 2,000,000 shares of Common Stock to the number of shares available for issuance under
the 2021 Plan, effective June&nbsp;12, 2024. Shares available for issuance under the 2021 Plan were previously registered on registration statements on Form <FONT STYLE="white-space:nowrap">S-8</FONT> filed with the Securities and Exchange
Commission on July&nbsp;16, 2021 (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-257941),</FONT> March&nbsp;9, 2022 (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-263380),</FONT> March&nbsp;8, 2023 (Registration <FONT
STYLE="white-space:nowrap">No.&nbsp;333-270343),</FONT> June&nbsp;16, 2023 (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-272733)</FONT> and March&nbsp;6, 2024 (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-277695).</FONT>
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The price of $8.42 per share, which is the average of the high and low sale prices of the Registrant&#146;s
Common Stock on the Nasdaq Global Market on June&nbsp;10, 2024, is set forth solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. </P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g820577dsp001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g820577dsp001.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M\-+">RE9RG?V:[.,OQ/T/,O$SA/#8*.*I8M8N56+Y*%.-Y]FI1:TL][GW/\
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MI7B'1;PS+::KHU]!J&GW#6TSV]PL-U;NR2-%<1R1L <JR$$ BA?D&WD8.O\
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M31O$&WJ'V;62^ZW]?UN+;^OZ_0YO]AOXT>/M)\=^*OV8/BO=WMYK7A*/5?\
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MS!=KJ*3&W^S>7\WF>9MQSFDU;0GKVUV_X!^,GQ0\3:?^TY^W#\-=-^'+G6-
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M5ZSW[/L> GIMROMV"D 4 '3V_3I0 4 % !_3]*-O(-O(* "@ H .GMC\,8H
M,?3C]*-@V"@ H ,4;>0;>0#C@< =AP!CVHV\@_0,?IT]J-OD&WR#I^'Z4;!L
M']/THV\@V\@H * %4#<.!P1^&#3CNO5 ]BQ700)@>@X]NF*5EVV#;R$VK_='
MY#M1RQ_E7W(+M>5C$UCPMX9\0B,:_P"'-"UP0?ZD:QI&GZF(?^N8O;>3R_\
M@.*X\1EF6XO_ 'K+\-B;:?O:%*II_P!OQ9W83,\RP%_J.88G!7=W["O5HZK9
M_NYQU7<31_"OA?PZ)!X?\-Z#H0F.9AH^CZ=I@E(X!D%E;Q[SC^]FC#Y9EV#_
M -TR_#87_KU0I4__ $B,1XO-,SQ\N;'9CBL;)=<1B*M9_?4G)FYM4?PJ,>P&
M,5V<L5]E*WD<-V+M'H/R%'*NR^X5PVCT'Y"CE79?<%PVCT'Y"CE79?<%PVCT
M'Y"CE79?<%PVCT'Y"CE79?<%PVCT'Y"CE79?<%PVCT'Y"CE79?<%PVCT'Y"C
ME79?<%PVCT'Y"CE79?<%PVCT'Y"CE79?<%PVCT'Y"CE79?<%PVCT'Y"CE79?
M<%PVCT'Y"CE79?<%PVCT'Y"CE79?<%PVCT'Y"CE79?<%PVCT'Y"CE79?<%PV
MCT'Y"CE79?<%PVCT'Y"CE79?<%PVCT'Y"CE79?<%PVCT'Y"CE79?<%PVCT'Y
C"CE79?<%PVCT'Y"CE79?<%PP!V Q[ 8Q19+HE;R 6F!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
